Page last updated: 2024-10-28

guaifenesin and ER-Negative PR-Negative HER2-Negative Breast Cancer

guaifenesin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ho, CY1
Hu, DW1
Chen, BR1
Yang, CC1
Yao, CH1
Ni, T1
Ho, WC1
Chen, YS1
Tu, CY1
Chang, WC1
Wu, YC1
Tang, CH1
Huang, HC1
Huang, WC1
Li, TS1

Other Studies

1 other study available for guaifenesin and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Snail Mucus Enhances Chemosensitivity of Triple-negative Breast Cancer
    Anticancer research, 2022, Volume: 42, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxo

2022